Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
2(29%)
Results Posted
0%(0 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

active_not_recruiting229%
terminated229%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7